NCT04016688 is a NA clinical trial of ESPB and TAP block in Postoperative Pain, sponsored by Fayoum University.

Who is sponsoring NCT04016688?

NCT04016688 is sponsored by Fayoum University.

What drugs are being tested in NCT04016688?

Interventions in NCT04016688: ESPB and TAP block.

What condition does NCT04016688 study?

NCT04016688 studies Postoperative Pain.

Is NCT04016688 still recruiting?

NCT04016688 is currently completed. Last updated 22 January 2020.

Last reviewed 2020-01-22 · How we verify

NCT04016688

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bilateral Erector Spinae Plane Block After Elective Cesarean Section

Completed NA Last updated 22 January 2020

What this trial tests

NA trial testing ESPB and TAP block in Postoperative Pain in 60 participants. Completed in 1 January 2020.

Timeline

8 July 2019

Primary endpoint
31 December 2019

1 January 2020

Quick facts

Lead sponsor	Fayoum University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	60
Start date	8 July 2019
Primary completion	31 December 2019
Estimated completion	1 January 2020
Sites	3 locations across Egypt

Drugs / interventions tested

ESPB and TAP block

Conditions studied

Postoperative Pain — all drugs for Postoperative Pain →

Sponsor

Fayoum University

Who can join

Adults 18 to 40, female only, with Postoperative Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of work is to assess and compare the analgesic efficacy of bilateral erector spinae plane block with that of bilateral transversus abdominis plane block after elective cesarean section.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparison of Analgesic Effect Between Erector Spinae Plane Block and Transversus Abdominis Plane Block After Elective Cesarean Section: A Prospective Randomized Single-Blind Controlled Study.
Boules ML, Goda AS, Abdelhady MA, Abu El-Nour Abd El-Azeem SA, et al · · 2020 · cited 31× · PMID 32547172 · DOI 10.2147/jpr.s253343

Verify or expand the search:

Other Fayoum University trials

Trials by the same sponsor.

NCT07536620 — Metformin and Alveolar Cleft · Phase 2 · not yet recruiting
NCT07444970 — Comparative Evaluation of Xenograft Alone and Sticky Bone in Sinus Lift With Concurrent Implant Placement · NA · not yet recruiting
NCT07394179 — Transforming Channel Osteotomy Into Tunnel Osteotomy in Zygomatic Implant Preparation · NA · not yet recruiting
NCT07277348 — Analysis of The Outcomes of Therapeutic Photorefractive Keratectomy Combined With Prophylactic Accelerated Cross-Linking · NA · not yet recruiting
NCT07330726 — Lidocaine Patch and Lower Third Molar · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04016688 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fayoum University
Last refreshed: 22 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04016688.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing